Glooko is a company startup that makes diabetes management easier, whether it is a person with diabetes, a clinician, or a disease management organization. Glooko’s FDA 510(k) cleared, HIPAA compliant diabetes management system starts with adding simplicity to keeping a logbook. With the Glooko mobile app and Glooko MeterSync Cable, patients can seamlessly download meter readings from a multitude of FDA-cleared glucose meters into their mobile device. This data is now accessible, annotatable, and sharable. Information uploaded by the patient can be shared with their provider through Glooko’s integrated online platform, available on supported web browsers.

Company Growth (employees)
Type
Private
HQ
Mountain View, US
Founded
2010
Size (employees)
106 (est)+13%
Website
glooko.com
Glooko was founded in 2010 and is headquartered in Mountain View, US

Key People/Management at Glooko

Rick Altinger

Rick Altinger

CEO
Yogen Dalal

Yogen Dalal

Co-founder & Chairman
Michael Greenfield

Michael Greenfield

Chief Medical Officer

Glooko Office Locations

Glooko has an office in Mountain View
Mountain View, US (HQ)
899 W Evelyn Ave

Glooko Financials and Metrics

Summary Metrics

Founding Date

2010

Total Funding

$71 m

Latest funding size

$35 m

Time since last funding

6 months

Investors

Glooko's latest funding round in June 2017 was reported to be $35 m. In total, Glooko has raised $71 m

Glooko Operating Metrics

Glooko's Patients Served was reported to be 1 m in Jun, 2017
Jun, 2017

Service Providers

6 k

Patients Served

1 m
Show all operating metrics

Glooko's Web-traffic and Trends

Glooko Online and Social Media Presence

Glooko News and Updates

Diabetes management platform Glooko raises $35 million

 Glooko, a startup selling data management healthcare service on top of a device-agnostic platform to make it easier for doctors to remotely monitor patients, has pulled in $35 million Series C funding. It had previously raised $36 million in various rounds, bringing the total up to $71 million. The…

Georgian Partners leads $35 mln Series C financing of Glooko

Glooko, a U.S. diabetes data management platform, has secured $35 million in Series C financing. The round was led by Canadian growth equity firm Georgian Partners and joined by new and existing investors, including Canaan Partners, Medtronic and Social Capital. Founded in 2010, Glooko is a develope…

Glooko Company Life and Culture

You may also be interested in